Severity index for rheumatoid arthritis and its association with health care costs and biologic therapy use in Turkey

Onur Baser, Erdem Baser (), Akif Altinbas () and Abdulkadir Burkan ()

Health Economics Review, 2013, vol. 3, issue 1, 1-7

Abstract: RA severity varies throughout Turkey and is a significant determinant of health care costs and biologic therapy use. Therefore, future comparative effectiveness studies should include the severity measure in their analysis. Copyright Baser et al.; licensee Springer. 2013

Keywords: Rheumatoid arthritis; Severity index; Medical costs; Real-world data analysis; Outcomes research (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1186/2191-1991-3-5 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:hecrev:v:3:y:2013:i:1:p:1-7:10.1186/2191-1991-3-5

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/13561

DOI: 10.1186/2191-1991-3-5

Access Statistics for this article

Health Economics Review is currently edited by J. Matthias Graf von der Schulenburg

More articles in Health Economics Review from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().